Home › Graves Disease › Michigan
Graves Disease clinical trials in Michigan
4 studies for Graves Disease are looking for participants at sites in Michigan.
Cities in Michigan
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-046, Farmington Hills
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Oct 1, 2026 · NCT07661056A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Metro Detroit Endocrinology Center, Dearborn
- Profound Research, Farmington Hills
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07570316Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 126, Flint
- Site 107, Livonia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1018, Farmington Hills
- Site Number - 1069, Flint
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT06727604From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.